Jeffrey William Henderson Qualcomm Inc (QCOM) insider trading activity

Jeffrey William Henderson is Director of QUALCOMM INC. Currently has a direct ownership of 6,408 shares of QCOM, which is worth approximately $989,779. The most recent transaction as insider was on Mar 10, 2024, when has been sold 2,056 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.41K

0% 3M change

47.24% 12M change

Total Value Held $989,779

Jeffrey William Henderson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 10 2024	BUY Exercise of conversion of derivative security	-	2,056 Added 24.29%	6,408 Common Stock
Mar 10 2023	SELL Sale (or disposition) back to the issuer	$123,138 $115.19 p/Share	1,069 Reduced 19.72%	4,352 Common Stock
Mar 10 2023	BUY Exercise of conversion of derivative security	-	3,316 Added 37.95%	5,421 Common Stock
Feb 23 2023	SELL Open market or private sale	$310,475 $124.19 p/Share	2,500 Reduced 54.29%	2,105 Common Stock
Feb 22 2023	SELL Open market or private sale	$310,125 $124.05 p/Share	2,500 Reduced 35.19%	4,605 Common Stock
Mar 12 2022	SELL Sale (or disposition) back to the issuer	$223,787 $152.34 p/Share	1,469 Reduced 17.13%	7,105 Common Stock
Mar 12 2022	BUY Exercise of conversion of derivative security	-	4,559 Added 34.71%	8,574 Common Stock
Apr 05 2021	SELL Sale (or disposition) back to the issuer	$187,060 $140.33 p/Share	1,333 Reduced 24.93%	4,015 Common Stock
Apr 05 2021	BUY Exercise of conversion of derivative security	-	4,134 Added 43.6%	5,348 Common Stock
Nov 10 2020	SELL Open market or private sale	$846,600 $141.1 p/Share	6,000 Reduced 83.17%	1,214 Common Stock
Mar 10 2020	SELL Sale (or disposition) back to the issuer	$118,098 $78.89 p/Share	1,497 Reduced 17.19%	7,214 Common Stock
Mar 10 2020	BUY Exercise of conversion of derivative security	-	4,644 Added 34.77%	8,711 Common Stock
Mar 08 2019	SELL Sale (or disposition) back to the issuer	$88,003 $53.53 p/Share	1,644 Reduced 28.79%	4,067 Common Stock
Mar 08 2019	BUY Exercise of conversion of derivative security	-	5,099 Added 47.17%	5,711 Common Stock
Mar 22 2018	SELL Sale (or disposition) back to the issuer	$14,284 $55.58 p/Share	257 Reduced 29.57%	612 Common Stock
Mar 22 2018	BUY Exercise of conversion of derivative security	-	795 Added 47.78%	869 Common Stock

Also insider at

HALO

HALOZYME THERAPEUTICS, INC. Healthcare

BDX

BECTON DICKINSON & CO Healthcare

Director

FGEN

FIBROGEN INC Healthcare

Director

JWH